Riyadh – Sharikat Mubasher: Aspen Pharmacare Holdings Limited, a global specialty and branded multinational pharmaceutical company, announced the opening of a new regional headquarters in Riyadh, strengthening its footprint in Saudi Arabia and the broader Middle East.

According to Aspen’s press release, this move is part of the company’s wider regional growth strategy, which centers on talent development, localization, and strategic partnerships.

Daniel Vella Friggieri, Regional CEO for Europe & Middle East at Aspen, stated: “We are delighted to be strengthening our local presence in this crucial market. The large-scale changes that have occurred in Saudi Arabia’s healthcare landscape offer us a tremendous opportunity.”

Now ranked among Aspen’s top five markets in the Middle East and Europe, Saudi Arabia has become a key focus for the pharmaceutical group. The Riyadh headquarters will also support several high-priority, Saudi-based initiatives.

Wesam Nehad, General Manager of Aspen Pharma RHQ, added: “Expanding in Saudi Arabia allows Aspen to build on our already well-established, strong capabilities across the Middle East – namely, an efficient distribution network, operational excellence, and a highly skilled team. As we continue to grow, we are committed to expanding our reach and enhancing patient access to high-quality, affordable medicine across the Kingdom and wider region.”

Aspen specializes in post-patent branded medicines and domestic brands across hospital and consumer markets, offering a wide range of pharmaceutical products including injectables, OTC drugs, and active pharmaceutical ingredients.